Stay updated with breaking news from Therapy Response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Navidea Biopharmaceuticals Reports Fourth Quarter 2021 Financial Results - read this article along with other careers information, tips and advice on BioSpace
and Corresponding Risk Reduction Over Time NEW YORK, June 28, 2021 - Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces new data demonstrating KidneyIntelX™ can be effective at monitoring therapeutic response and improvements in kidney health over time in adults with type 2 diabetes. By accurately assessing therapeutic response, particularly in patients at high risk for kidney failure, KidneyIntelX can potentially address a major barrier for primary care physicians and specialists in using new pharmaceuticals to slow kidney...